Compare tickers
Up to 5 tickers, ~30 metrics, weighted verdict. Best in green, worst in red.
Verdict
Weighted score 0-100 across 1 tickers · best in green
25
25
15
20
15
Total: 100 · normalized in scoring
#1
BMY
score 50.0
Momentum ranks weakest at 50 with negative 11.81% three-month return dragging overall score to middle-tier position.
value 50growth 50quality 50momentum 50sentiment 50
BMY
Bristol-Myers Squibb Company
$54.97
+0.94%
BMY
Bristol-Myers Squibb Company
$54.97
+0.94%
Snapshot
Price
54.97
Day %
0.94
1M %
-4.2
3M %
-11.81
YTD %
2.82
Market cap
112252657664.0
ADV ($)
636848792.5023193
Beta
0.259
Tao zone
Current zone
Pullback
Dist 21-EMA %
-3.59
Dist ATR (σ)
-1.49
Tao grade
C
Confluence
3
Valuation
P/E (ttm)
15.397759
P/E (fwd)
8.914729
P/S
2.315347
EV/EBITDA
7.757
P/B
5.593203
FCF yield
0.0878
PEG
174.17
Growth
Revenue yoy
0.026
EPS yoy
0.092
FCF yoy
—
Quality
Gross margin
0.71981
Operating margin
0.33040002
Net margin
0.15006
ROE
0.38731998
ROA
0.10689
Debt / Equity
2.31
Interest cov.
5.93
Technicals
RSI(14)
37.8
MACD signal
bear
vs 50-DMA
-5.35
vs 200-DMA
3.47
vs 52w high
-12.59
HV-30
27.1
Sentiment
Analyst rec
2.51724
Target upside
14.75
Insider buy-sell 90d
—
Risk
Short interest
1.7999999999999998
Days to cover
3.65
Next earnings
2026-07-30
Full BMY dashboard →